Towards inverse modeling of intratumor heterogeneity

被引:1
|
作者
Brutovsky, Branislav [1 ]
Horvath, Denis [2 ]
机构
[1] Safarik Univ, Fac Sci, Dept Biophys, Jesenna 5, Kosice 04154, Slovakia
[2] Safarik Univ, Fac Sci, Ctr Interdisciplinary Biosci, Kosice 04154, Slovakia
来源
OPEN PHYSICS | 2015年 / 13卷 / 01期
关键词
Markov processes; intratumor heterogeneity; phenotype switching; CANCER STEM-CELLS; STOCHASTIC GENE-EXPRESSION; PHENOTYPIC DIVERSITY; EPIGENETIC LANDSCAPE; NOISE; PLASTICITY; EVOLUTION; TRANSITIONS; ATTRACTORS; SURVIVAL;
D O I
10.1515/phys-2015-0032
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Development of resistance limits efficiency of present anticancer therapies and preventing it remains a big challenge in cancer research. It is accepted, at the intuitive level, that resistance emerges as a consequence of the heterogeneity of cancer cells at the molecular, genetic and cellular levels. Produced by many sources, tumor heterogeneity is extremely complex time dependent statistical characteristics which may be quantified by measures defined in many different ways, most of them coming from statistical mechanics. In this paper, we apply the Markovian framework to relate population heterogeneity to the statistics of the environment. As, from an evolutionary viewpoint, therapy corresponds to a purposeful modification of the cells' fitness landscape, we assume that understanding general relationship between the spatio-temporal statistics of a tumor microenvironment and intratumor heterogeneity will allow to conceive the therapy as an inverse problem and to solve it by optimization techniques. To account for the inherent stochasticity of biological processes at cellular scale, the generalized distance based concept was applied to express distances between probabilistically described cell states and environmental conditions, respectively.
引用
收藏
页码:232 / 241
页数:10
相关论文
共 50 条
  • [1] Modeling intratumor heterogeneity in breast cancer
    Mcdonough, Elizabeth
    Barroso, Margarida
    Ginty, Fiona
    Corr, David T.
    BIOFABRICATION, 2025, 17 (01)
  • [2] Towards rationale therapy: Dealing with intertumor and intratumor heterogeneity
    Amir, El-ad David
    Litvin, Oren
    Levine, Jacob
    Bendall, Sean C.
    Davis, Kara L.
    Simonds, Erin F.
    Schild, Tanya
    Rocco, Mark
    Rosen, Neal
    Nolan, Garry P.
    Pe'er, Dana
    CANCER RESEARCH, 2013, 73
  • [3] Modeling intratumor heterogeneity through CRISPR-barcodes
    Guernet, Alexis
    Aaronson, Stuart A.
    Anouar, Youssef
    Grumolato, Luca
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (06)
  • [4] Intratumor heterogeneity, a Darwinian stumbling block towards personalized medicine?
    Billaud, Marc
    M S-MEDECINE SCIENCES, 2012, 28 (12): : 1116 - 1119
  • [5] Modeling Breast Cancer Intertumor and Intratumor heterogeneity Using Xenografts
    Bruna, Alejandra
    Rueda, Oscar M.
    Caldas, Carlos
    TARGETING CANCER, VOL 81, 2016, 2016, 81 : 227 - 230
  • [6] Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling
    Niida, Atsushi
    Nagayama, Satoshi
    Miyano, Satoru
    Mimori, Koshi
    CANCER SCIENCE, 2018, 109 (04) : 884 - 892
  • [7] Intratumor heterogeneity in HCC
    Friemel, Juliane
    Frick, Lukas
    Weber, Achim
    AGING-US, 2015, 7 (06): : 350 - 351
  • [8] INTRATUMOR IMMUNOLOGICAL HETEROGENEITY
    MILLER, FR
    GRISWOLD, DE
    HEPPNER, GH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 27 - 27
  • [9] Evolutionary Dynamics of Intratumor Heterogeneity
    Iwasa, Yoh
    Michor, Franziska
    PLOS ONE, 2011, 6 (03):
  • [10] The Origins and Implications of Intratumor Heterogeneity
    Michor, Franziska
    Polyak, Kornelia
    CANCER PREVENTION RESEARCH, 2010, 3 (11) : 1361 - 1364